Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIO) Sees Large Increase in Short Interest

Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIO) was the recipient of a significant increase in short interest in November. As of November 30th, there was short interest totalling 1,550,000 shares, an increase of 261.3% from the November 15th total of 429,000 shares. Based on an average trading volume of 5,300,000 shares, the days-to-cover ratio is currently 0.3 days. Approximately 4.5% of the company’s stock are sold short.

Cardio Diagnostics Trading Up 27.7 %

CDIO stock traded up $0.30 during midday trading on Wednesday, hitting $1.38. 9,176,615 shares of the company traded hands, compared to its average volume of 1,956,522. Cardio Diagnostics has a twelve month low of $0.19 and a twelve month high of $3.56. The business has a 50 day simple moving average of $0.30 and a 200-day simple moving average of $0.41.

Wall Street Analyst Weigh In

Separately, Benchmark restated a “speculative buy” rating and set a $2.00 target price on shares of Cardio Diagnostics in a report on Tuesday, August 27th.

About Cardio Diagnostics

Cardio Diagnostics Holdings, Inc develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease.